SCHEMBL13948751

SCHEMBL13948751

Cc1ccc(CC(=O)OC(C)(C)C)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
CCNB2 O95067 1/20 0.37
CCNE2 O96020 1/20 0.37
CDK1 P06493 1/20 0.37
CDK4 P11802 1/20 0.37
CCNB1 P14635 1/20 0.37
CCND1 P24385 1/20 0.37
CCNE1 P24864 1/20 0.37
CDK2 P24941 1/20 0.37
CCNB3 Q8WWL7 1/20 0.37
MTNR1A P48039 5/20 0.36
MTNR1B P49286 5/20 0.36
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4178339 0.85 ESR1 (0.41) KDM4EALDH1A1CCNB2CCNE2CDK1
SCHEMBL16749998 0.83 DGAT1 (0.40) KDM4EALDH1A1MAPTRAB9ACCNB2
SCHEMBL15174151 0.83 MTNR1A (0.39) KDM4EALDH1A1RAB9ACCNB2CCNE2
SCHEMBL30027206 0.83 DGAT1 (0.40) KDM4EALDH1A1MAPTRAB9ACCNB2
SCHEMBL10174364 0.81 RAB9A (0.44) KDM4EALDH1A1MAPTRAB9AKEAP1
SCHEMBL27891065 0.81 CACNA1I (0.41) KDM4EALDH1A1MAPTCCNB2CCNE2
SCHEMBL4837238 0.80 MTNR1A (0.39) KDM4EALDH1A1CCNB2CCNE2CDK1
SCHEMBL1135124 0.80 SMN1; SMN2 (0.46) KDM4EALDH1A1MAPTHSD17B10HPGD
SCHEMBL7229581 0.79 RAB9A (0.44) KDM4EALDH1A1MAPTRAB9AKEAP1
SCHEMBL4841414 0.79 CACNA1H (0.44) ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1885695-B1 INDOLINE COMPOUNDS FOURNIER LAB SA (FR) 2009-02-25 EP disclosed
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed
WO-2007000550-A2 NOVEL INDOLINE COMPOUNDS LABORATOIRES FOURNIER S.A. (FR) 2007-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 KDM4E 1574/4885ALDH1A1 1819/4885MAPT 763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.